Clinical trial
Biomarkers and Disease Activity in Patients Treated With Teriflunomide (Aubagio)
NCT03561402
Study timeline
Study start (actual)2016-12-01Date precision: day
Registry last updated2021-03-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosis, Relapsing-Remittingunresolved
Interventions
TeriflunomideDRUG · verified · RxNorm: teriflunomide
Sponsors & collaborators
McGill Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03561402 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.